|
1
|
Mirabello L, Troisi RJ and Savage SA:
osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyers PA, Heller G, Healey J, Huvos A,
Lane J, Marcove R, Applewhite A, Vlamis V and Rosen G: Chemotherapy
for nonmetastatic osteogenic sarcoma: The memorial sloan-kettering
experience. J Clin Oncol. 10:5–15. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto A and Iwamoto Y: Current status
and perspectives regarding the treatment of osteo-sarcoma:
Chemotherapy. Rev Recent Clin Trials. 3:228–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rytting M, Pearson P, Raymond AK, Ayala A,
Murray J, Yasko AW, Johnson M and Jaffe N: Osteosarcoma in
preadolescent patients. Clin Orthop Relat Res. 373:39–50. 2000.
View Article : Google Scholar
|
|
5
|
Kushlinskii NE, Fridman MV and Braga EA:
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis.
Biochemistry (Mosc). 81:315–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Z, Shen J, Chan MT and Wu WK:
MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.
J Cell Mol Med. 21:315–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhi X, Wu K, Yu D, Wang Y, Yu Y, Yan P and
Lv G: MicroRNA-494 inhibits proliferation and metastasis of
osteosarcoma through repressing insulin receptor substrate-1. Am J
Transl Res. 8:3439–3447. 2016.PubMed/NCBI
|
|
8
|
Yao J, Qin L, Miao S, Wang X and Wu X:
Overexpression of miR-506 suppresses proliferation and promotes
apoptosis of osteosarcoma cells by targeting astrocyte elevated
gene-1. Oncol Lett. 12:1840–1848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin Z, Ding H, He E, Chen J and Li M:
Up-regulation of microRNA-491-5p suppresses cell proliferation and
promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell
Prolif. 50:doi: 10.1111/cpr.12308.
|
|
10
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Zheng C, Jiang K, He J, Cao X and
Wu S: MicroRNA-503 suppresses cell proliferation and invasion in
osteosarcoma via targeting insulin-like growth factor 1 receptor.
Exp Ther Med. 14:1547–1553. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng Y, Luan F, Zeng L, Zhang Y and Ma K:
MiR-429 suppresses the progression and metastasis of osteosarcoma
by targeting ZEB1. EXCLI J. 16:618–627. 2017.PubMed/NCBI
|
|
14
|
Wang C, Ba X, Guo Y, Sun D, Jiang H, Li W,
Huang Z, Zhou G, Wu S, Zhang J and Chen J: MicroRNA-199a-5p
promotes tumour growth by dual-targeting PIAS3 and p27 in human
osteosarcoma. Sci Rep. 7:414562017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang SN, Luo S, Liu C, Piao Z, Gou W, Wang
Y, Guan W, Li Q, Zou H, Yang ZZ, et al: miR-491 inhibits
osteosarcoma lung metastasis and chemoresistance by targeting
αB-crystallin. Mol Ther. 25:2140–2149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duan J, Liu J, Liu Y, Huang B and Rao L:
miR-491-3p suppresses the growth and invasion of osteosarcoma cells
by targeting TSPAN1. Mol Med Rep. 16:5568–5574. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu ZX, Hong L, Fang SQ, Tan GH, Huang PG,
Zeng Z, Xia X and Wang XX: Overexpression of pyruvate kinase M2
predicts a poor prognosis for patients with osteosarcoma. Tumour
Biol. 37:14923–14928. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang D, Wu J, Guo L, Xu Y, Liu L and Lu
J: Metformin increases sensitivity of osteosarcoma stem cells to
cisplatin by inhibiting expression of PKM2. Int J Oncol.
50:1848–1856. 2017. View Article : Google Scholar : PubMed/NCBI
|
